ClinConnect ClinConnect Logo
Search / Trial NCT02879201

Continuous Venovenous Hemodiafiltration Versus Sustained Low-efficiency Hemodialysis for Critically Ill Patients With Acute Kidney Injury in Intensive Care Unit

Launched by BANGKOK METROPOLITAN ADMINISTRATION MEDICAL COLLEGE AND VAJIRA HOSPITAL · Aug 22, 2016

Trial Information

Current as of May 03, 2025

Completed

Keywords

ClinConnect Summary

The investigators performed a single center experience accumulated over 12 months since February 2009 with a continuous venovenous hemodiafiltration (CVVHDF) and hybrid technique named sustained low-efficiency dialysis (SLED). The primary end point was death from any cause by day 30. Intensive care unit (ICU) patients were eligible for inclusion when serum creatinine was \> 2 mg/dL, and renal replacement therapy (RRT) was initiated. The selected patients were treated with CVVHDF or SLED.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • - The inclusion criteria were
  • 1. AKI requiring RRT
  • 2. Hemodynamic instability defined by systolic blood pressure ≤ 90 mmHg and/or diastolic blood pressure ≤ 60 mmHg
  • 3. Patients requiring initiation to vasopressor support
  • Exclusion Criteria:
  • Patients with pre-existing chronic kidney disease ( eGFR less than 30 mLmin/1.73m2) were excluded

About Bangkok Metropolitan Administration Medical College And Vajira Hospital

The Bangkok Metropolitan Administration Medical College and Vajira Hospital is a leading healthcare institution in Thailand, dedicated to advancing medical education, research, and patient care. With a commitment to excellence, the institution supports a wide range of clinical trials aimed at enhancing medical knowledge and improving health outcomes. By fostering collaboration among healthcare professionals, researchers, and patients, it plays a pivotal role in the development of innovative therapies and interventions, contributing significantly to the global healthcare landscape. The institution emphasizes ethical practices and rigorous scientific standards in all its clinical research initiatives.

Locations

Bangkok, , Thailand

Patients applied

0 patients applied

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials